Literature DB >> 26174583

Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management.

T Delory1, E Seringe2, G Antoniotti3, I Novakova1, C Goulenok3, I Paysant3, S Boyer4, A Carbonne5, T Naas6, P Astagneau7.   

Abstract

BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are becoming of immediate concern for infection control policies. Prompt detection of CPE on health care setting admission is crucial to halt the spread of an outbreak. We report a cluster of 13 Klebsiella pneumoniae carbapenemase (KPC)-2-producing K pneumoniae cases in a tertiary care hospital.The objective of this study was to identify contributing factors originating the outbreak.
METHODS: An outbreak investigation was conducted using descriptive epidemiology, observation of health care practices, and interviews of management staff. A root cause analysis was performed to identify patent and latent failures of infection control measures using the association of litigation and risk management method.
RESULTS: The main patent failure was the delay in identifying KPC-2-producing K pneumoniae carriers. Contributing factors were work and environmental factors: understaffing, lack of predefined protocols, staff members' characteristics, and underlying patients' characteristics. Latent failures were as follows: no promotion of the national guidelines for prevention of CPE transmission, no clear procedure for the management of patients hospitalized abroad, no clear initiative for promoting a culture of quality in the hospital, biologic activity recently outsourced to a private laboratory, and poor communication among hospital members.
CONCLUSION: Clinical management should be better promoted to control hospital outbreaks and should include team work and safety culture.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem-producing enterobacteriaceae; Infection control; Outbreak; Root causes analysis

Mesh:

Substances:

Year:  2015        PMID: 26174583     DOI: 10.1016/j.ajic.2015.05.021

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Coping and growing in dilemma: Clinical work experience of front-line nurses in Wuhan during the early stage of COVID-19 epidemic.

Authors:  Fen Xu; Ju-Ping Tang; Sha Lu; Hong-Wei Fang; Lili Dong; Yun-Xian Zhou
Journal:  Jpn J Nurs Sci       Date:  2021-05-11       Impact factor: 1.691

3.  Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province/ Iraq.

Authors:  Sareaa Maseer Gatya Al-Mayahie; Dhifar Raa'd Taher Al-Guranie; Aya Aziz Hussein; Zaineb Ali Bachai
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

4.  Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015.

Authors:  Narimane Nekkab; Pascal Crépey; Pascal Astagneau; Lulla Opatowski; Laura Temime
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

5.  Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong.

Authors:  Vincent C C Cheng; Shuk-Ching Wong; Vivien W M Chuang; Simon Y C So; Jonathan H K Chen; Siddharth Sridhar; Kelvin K W To; Jasper F W Chan; Ivan F N Hung; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  Am J Infect Control       Date:  2020-05-24       Impact factor: 2.918

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.